Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...
During a fireside chat with Scripta Insights’ CEO, Cuban discussed TrumpRx and unveiled new MCCPDC innovations, including ...
Consumers will be able to buy discounted brand-name drugs through a government direct sales exchange called Trump Rx, ...
Novo Nordisk moved to cut U.S. prices on its leading GLP-1 weight-loss and diabetes drugs as competitive pressure from Eli ...
President Donald Trump has announced a slew of programs aimed at saving Americans money on prescription drugs, including a new website that will allow patients to buy them directly at discounted rates ...
By moving early, Novo Nordisk has got in with its price cut ahead of Lilly, whose deal involved dual GLP-1/CIP agonist ...
Under its terms, those products will be sold by their developers through a planned national online drug platform called ...
Novo Nordisk has lost ground in the weight-loss drug market to Eli Lilly and telehealth companies. The company's new CEO is ...
In a landmark deal announced Thursday, President Donald Trump negotiated dramatically lower costs for weight-loss drugs produced by pharmaceutical giants Eli Lilly and Novo Nordisk, which could benefi ...
After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...